(Q40430655)

20 September 2017

1 reference

title

Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy (English)

1 reference

20 September 2017

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

platelet membrane glycoproteins

25 May 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586333

glycoprotein Ib-IX-V complex

25 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586333

25 May 2024

author name string

B. S. Coller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586333

25 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

full work available at URL

20 September 2017

https://www.ahajournals.org/doi/full/10.1161/01.CIR.92.9.2373

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

25 May 2024

1 reference

20 September 2017

volume

92

1 reference

20 September 2017

issue

9

1 reference

20 September 2017

page(s)

2373-2380

1 reference

THROMBASTHENIA. STUDIES ON THREE CASES

20 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

The effect of salicylates on the hemostatic properties of platelets in man

25 May 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion

25 May 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's Thrombasthenia

25 May 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes

25 May 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Exposure of platelet fibrinogen receptors by ADP and epinephrine

25 May 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen

25 May 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody

25 May 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa

25 May 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors

25 May 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Integrins: versatility, modulation, and signaling in cell adhesion

25 May 2024

24

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Vitronectin and its receptors

25 May 2024

27

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets

25 May 2024

29

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets

25 May 2024

36

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate

25 May 2024

37

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Platelets and thrombolytic therapy

25 May 2024

38

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury

25 May 2024

43

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Epinephrine potentiation of in viw stimuli reverses aspirin inhibition of platelet thrombos formation in stenosed canine coronary arteries

25 May 2024

46

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Pathology of arterial thrombosis

25 May 2024

47

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Clinical implications of prostaglandin and thromboxane A2 formation (1).

25 May 2024

49

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs

25 May 2024

50

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart

25 May 2024

51

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody

25 May 2024

52

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

25 May 2024

53

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents

25 May 2024

56

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury

25 May 2024

57

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty

25 May 2024

58

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody

25 May 2024

59

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

25 May 2024

70

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

25 May 2024

71

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

Therapeutic-class wars--drug promotion in a competitive marketplace

25 May 2024

76

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2373

25 May 2024

Identifiers

1 reference

20 September 2017

1 reference